Oticon Medical gets FDA approval for cochlear implant

Demant's surgical division Oticon Medical can now launch the cochlear implant system Neuro in the US after receiving marketing authorization from the country's authorities.

Photo: Jens Dresling

After a long wait, Demant's bone conduction division Oticon Medical has received US marketing authorization for the cochlear implant system Neuro, according to a Thursday press release.

Oticon Medical has developed the Neurosystem itself after taking over French Neurelec, and the current authorization covers adults with severe-to-profound hearing loss.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs